Insilico Medicine raises $255m in Series C

Insilico Medicine, an AI-based platform for drug development and discovery, announced $255m in Series C financing.

Made.com lists on the London Stock Exchange

min read

Neo4j raises $325m at a $2bn+ valuation

min read

Whatfix raises $90 million Series D

min read

Eight Roads Ventures China backs DeepMirror

min read

Related Articles